Meixiang Yu
Overview
Explore the profile of Meixiang Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
901
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Appleton J, Funk Q, Fregonara P, Yu M, Faridar A, Nakawah M, et al.
Neurology
. 2025 Feb;
102(7_supplement_1):6312.
PMID: 39977907
Objective: To study neuroinflammation in early-onset Alzheimer's disease (AD) and its brain topography, compared with that of tau and amyloid. Background: Neuroinflammation is a potential therapeutic target in AD. Translocator...
2.
3.
Appleton J, Finn Q, Zanotti-Fregonara P, Yu M, Faridar A, Nakawah M, et al.
Brain
. 2024 Jul;
148(1):119-132.
PMID: 39013020
Brain inflammation, with an increased density of microglia and macrophages, is an important component of Alzheimer's disease and a potential therapeutic target. However, it is incompletely characterized, particularly in patients...
4.
Yu M, Li X, Zong L, Wang Z, Lv Q
Anatol J Cardiol
. 2023 Nov;
28(1):35-43.
PMID: 37961898
Background: A novel risk prediction model appears to be urgently required to improve the assessment of thrombotic risk in overweight patients with nonvalvular atrial fibrillation (NVAF). We developed a novel...
5.
Yu M, Wang Z, Zong L, Xu Q, Li X, Lv Q
Int J Clin Pharm
. 2022 Jul;
44(5):1149-1157.
PMID: 35842869
Background: Guidance for dabigatran and rivaroxaban in overweight patients diagnosed with non-valvular atrial fibrillation (NVAF) is still lacking. Aim: Compare the effectiveness and safety of dabigatran and rivaroxaban for the...
6.
Ma X, Hao C, Yu M, Zhang Z, Huang J, Yang W
Evid Based Complement Alternat Med
. 2022 May;
2022:7291434.
PMID: 35615688
Quercetin (QUE), a health supplement, can improve renal function in diabetic nephropathy (DN) rats by ameliorating podocyte injury. Its clinical trial for renal insufficiency in advanced diabetes (NCT02848131) is currently...
7.
Li W, Wang Y, Lohith T, Zeng Z, Tong L, Mazzola R, et al.
Sci Transl Med
. 2022 Jan;
14(627):eabg3684.
PMID: 35020407
Positron emission tomography (PET) ligands play an important role in the development of therapeutics by serving as target engagement or pharmacodynamic biomarkers. Here, we describe the discovery and translation of...
8.
Pascual B, Funk Q, Zanotti-Fregonara P, Cykowski M, Veronese M, Rockers E, et al.
Brain
. 2021 Apr;
144(5):1565-1575.
PMID: 33824991
Despite epidemiological and genetic data linking semantic dementia to inflammation, the topography of neuroinflammation in semantic dementia, also known as the semantic variant of primary progressive aphasia, remains unclear. The...
9.
Rocha N, Charron O, Latham L, Colpo G, Zanotti-Fregonara P, Yu M, et al.
Neurol Neuroimmunol Neuroinflamm
. 2021 Apr;
8(3).
PMID: 33795375
Objective: To define the role played by microglia in different stages of Huntington disease (HD), we used the TSPO radioligand [11C]-ER176 and PET to evaluate microglial activation in relation to...
10.
Veronese M, Tuosto M, Marques T, Howes O, Pascual B, Yu M, et al.
Mol Imaging Biol
. 2021 Jan;
23(4):560-571.
PMID: 33475944
Purpose: The aim of this study was to investigate the use of spectral analysis (SA) for voxel-wise analysis of TSPO PET imaging studies. TSPO PET quantification is methodologically complicated by...